BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36898287)

  • 1. Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies.
    Zhang Z; Wang S; Zhu Z; Nie B
    Comput Biol Med; 2023 May; 157():106724. PubMed ID: 36898287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis.
    Wang H; Cheng W; Hu P; Ling T; Hu C; Chen Y; Zheng Y; Wang J; Zhao T; You Q
    Front Immunol; 2024; 15():1335112. PubMed ID: 38476236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics and machine-learning screening for immune-related genes in diagnosing non-alcoholic fatty liver disease with ischemic stroke and RRS1 pan-cancer analysis.
    Bao H; Li J; Zhang B; Huang J; Su D; Liu L
    Front Immunol; 2023; 14():1113634. PubMed ID: 37090698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WGCNA combined with machine learning to find potential biomarkers of liver cancer.
    Lv JH; Hou AJ; Zhang SH; Dong JJ; Kuang HX; Yang L; Jiang H
    Medicine (Baltimore); 2023 Dec; 102(50):e36536. PubMed ID: 38115320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.
    Cao Y; Du Y; Jia W; Ding J; Yuan J; Zhang H; Zhang X; Tao K; Yang Z
    Front Endocrinol (Lausanne); 2023; 14():1125829. PubMed ID: 36923221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.
    Cao J; Zhong Q; Huang Y; Zhu M; Wang Z; Xiong Z
    Biochem Biophys Res Commun; 2023 Dec; 686():149180. PubMed ID: 37922570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma.
    Lewinska M; Santos-Laso A; Arretxe E; Alonso C; Zhuravleva E; Jimenez-Agüero R; Eizaguirre E; Pareja MJ; Romero-Gómez M; Arrese M; Suppli MP; Knop FK; Oversoe SK; Villadsen GE; Decaens T; Carrilho FJ; de Oliveira CP; Sangro B; Macias RIR; Banales JM; Andersen JB
    EBioMedicine; 2021 Nov; 73():103661. PubMed ID: 34740106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.
    Ouyang G; Wu Z; Liu Z; Pan G; Wang Y; Liu J; Guo J; Liu T; Huang G; Zeng Y; Wei Z; He S; Yuan G
    Front Immunol; 2023; 14():1251750. PubMed ID: 37822923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of co-pathogenic genes of non-alcoholic fatty liver disease and hepatocellular carcinoma.
    Chen T; Zhang S; Zhou D; Lu P; Mo X; Tamrakar R; Yang X
    Front Oncol; 2022; 12():911808. PubMed ID: 36033523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating single-cell and bulk sequencing data to identify glycosylation-based genes in non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
    Zhou Z; Gao Y; Deng L; Lu X; Lai Y; Wu J; Chen S; Li C; Liang H
    PeerJ; 2024; 12():e17002. PubMed ID: 38515461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of key biomarkers associated with macrophages in nonalcoholic fatty liver disease based on hdWGCNA and machine learning.
    Li R; Zhao M; Miao C; Shi X; Lu J
    Aging (Albany NY); 2023 Dec; 15(24):15451-15472. PubMed ID: 38147020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer's disease through machine learning algorithms.
    Jiang L; Wang Q; Jiang Y; Peng D; Zong K; Li S; Xie W; Zhang C; Li K; Wu Z; Huang Z
    Clin Chim Acta; 2024 Apr; 557():117892. PubMed ID: 38537674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses.
    Li G; Li H; Chen Z
    Front Endocrinol (Lausanne); 2023; 14():1161269. PubMed ID: 37274336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of cuproptosis-related molecular clusters in non-alcoholic fatty liver disease.
    Liu C; Fang Z; Yang K; Ji Y; Yu X; Guo Z; Dong Z; Zhu T; Liu C
    J Cell Mol Med; 2024 Feb; 28(3):e18091. PubMed ID: 38169083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
    Bertot LC; Adams LA
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease.
    Cai C; Song X; Yu C
    Cancer Biomark; 2020; 29(1):69-78. PubMed ID: 32623384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of Biomarkers in Liver Tissue after Bariatric Surgery Based on WGCNA and SVM-RFE Algorithms.
    Jiang Y; Wang Y; Chen S; Liu Z; Yang H; Jiao Y; Tang L
    Dis Markers; 2023; 2023():2970429. PubMed ID: 36755803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.
    Hwang A; Shi C; Zhu E; Naaz F; Zhou P; Rasheed Z; Liu M; Jung LS; Duan B; Li J; Jiang K; Paka L; Gadhiya SV; Dana D; Ali Q; Yamin MA; Goldberg ID; Narayan P
    PLoS One; 2018; 13(6):e0198937. PubMed ID: 29944670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease.
    Nazari E; Khalili-Tanha G; Asadnia A; Pourali G; Maftooh M; Khazaei M; Nasiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
    Sci Rep; 2023 Nov; 13(1):20489. PubMed ID: 37993474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.